We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Viridian Therapeutics, Inc. (Nasdaq: VRDN), today announced the appointment of Jennifer Moses, CPA to the Company's Board of Directors and as Chair of the Audit Committee.